Related references
Note: Only part of the references are listed.Pseudomonas aeruginosa adaptation in cystic fibrosis patients increases C5a levels and promotes neutrophil recruitment
Margalida Mateu-Borras et al.
VIRULENCE (2022)
The biofilm life cycle: expanding the conceptual model of biofilm formation
Karin Sauer et al.
NATURE REVIEWS MICROBIOLOGY (2022)
Correlation of phenotypic and genotypic virulence markers, antimicrobial susceptibility pattern, and outcome of Pseudomonas aeruginosa sepsis infection
Juliana Alamu et al.
MICROBIAL PATHOGENESIS (2022)
The structure-function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment
Mads Lichtenberg et al.
FEMS MICROBIOLOGY REVIEWS (2022)
The lytic polysaccharide monooxygenase CbpD promotes Pseudomonas aeruginosa virulence in systemic infection
Fatemeh Askarian et al.
NATURE COMMUNICATIONS (2021)
Pathogenesis of Gram-Negative Bacteremia
Caitlyn L. Holmes et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Irene Jurado-Martin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects
Karl A. Glen et al.
PATHOGENS (2021)
Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis
Amy Pham et al.
INFECTION AND IMMUNITY (2021)
The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
Steven M. Huszczynski et al.
PATHOGENS (2020)
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program
Daniel J. Diekema et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Treatment with the Pseudomonas aeruginosa Glycoside Hydrolase PslG Combats Wound Infection by Improving Antibiotic Efficacy and Host Innate Immune Activity
Matthew J. Pestrak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The Diverse Functional Roles of Elongation Factor Tu (EF-Tu) in Microbial Pathogenesis
Kate L. Harvey et al.
FRONTIERS IN MICROBIOLOGY (2019)
Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa
Abeer M. Abd El-Aziz et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Ecotin, a microbial inhibitor of serine proteases, blocks multiple complement dependent and independent microbicidal activities of human serum
Zoltan Attila Nagy et al.
PLOS PATHOGENS (2019)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Bacterial Outer Membrane Vesicles Induce Vitronectin Release Into the Bronchoalveolar Space Conferring Protection From Complement-Mediated Killing
Magnus Paulsson et al.
FRONTIERS IN MICROBIOLOGY (2018)
Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacteria Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation
Fabien Bastaert et al.
FRONTIERS IN IMMUNOLOGY (2018)
Sensing Mg2+ contributes to the resistance of Pseudomonas aeruginosa to complement-mediated opsonophagocytosis
Mohammad Qadi et al.
ENVIRONMENTAL MICROBIOLOGY (2017)
Psl Produced by Mucoid Pseudomonas aeruginosa Contributes to the Establishment of Biofilms and Immune Evasion
Christopher J. Jones et al.
MBIO (2017)
Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity
Pamela S. Hair et al.
PLOS ONE (2017)
The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence
Tomasz Olszak et al.
SCIENTIFIC REPORTS (2017)
Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria
Joshua T. Thaden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Lipopolysaccharide modification in Gram-negative bacteria during chronic infection
Rita F. Maldonado et al.
FEMS MICROBIOLOGY REVIEWS (2016)
Complement activation, regulation, and molecular basis for complement-related diseases
Goran Bajic et al.
EMBO JOURNAL (2015)
Identification of OprF as a Complement Component C3 Binding Acceptor Molecule on the Surface of Pseudomonas aeruginosa
Meenu Mishra et al.
INFECTION AND IMMUNITY (2015)
Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa
Magnus Paulsson et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Complement system part II: role in immunity
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections
Carmen Pena et al.
CLINICAL INFECTIOUS DISEASES (2015)
Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack
Teresia Hallstroem et al.
PLOS ONE (2015)
Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing
Timothy J. Wells et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Bacterial and Clinical Characteristics of Health Care- and Community-Acquired Bloodstream Infections Due to Pseudomonas aeruginosa
Angela Hattemer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
Carmen Pena et al.
CLINICAL INFECTIOUS DISEASES (2013)
Recognition of lipid A variants by the TLR4-MD-2 receptor complex
Nina Maeshima et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Pseudomonas aeruginosa Small Protease (PASP), a Keratitis Virulence Factor
Aihua Tang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization
Meenu Mishra et al.
CELLULAR MICROBIOLOGY (2012)
Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa
Etsuko Sugawara et al.
FEBS JOURNAL (2012)
Absence of the lectin activation pathway of complement does not increase susceptibility to Pseudomonas aeruginosa infections
Hany Ibrahim Kenawy et al.
IMMUNOBIOLOGY (2012)
Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies
Hui Li et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Pseudomonas aeruginosa Alkaline Protease Blocks Complement Activation via the Classical and Lectin Pathways
Alexander J. Laarman et al.
JOURNAL OF IMMUNOLOGY (2012)
Dihydrolipoamide Dehydrogenase of Pseudomonas aeruginosa Is a Surface-Exposed Immune Evasion Protein That Binds Three Members of the Factor H Family and Plasminogen
Teresia Hallstroem et al.
JOURNAL OF IMMUNOLOGY (2012)
Pseudomonas aeruginosa Elastase Provides an Escape from Phagocytosis by Degrading the Pulmonary Surfactant Protein-A
Zhizhou Kuang et al.
PLOS ONE (2011)
Genetic and functional diversity of Pseudomonas aeruginosa lipopolysaccharide
Joseph S. Lam et al.
FRONTIERS IN MICROBIOLOGY (2011)
Pseudomonas aeruginosa: resistance to the max
Keith Poole
FRONTIERS IN MICROBIOLOGY (2011)
Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl
Michael J. Franklin et al.
FRONTIERS IN MICROBIOLOGY (2011)
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
Michael Hogardt et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Role of Neutrophils, MyD88-Mediated Neutrophil Recruitment, and Complement in Antibody-Mediated Defense against Pseudomonas aeruginosa Keratitis
Tanweer S. Zaidi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Properties of PASP: A Pseudomonas Protease Capable of Mediating Corneal Erosions
Aihua Tang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Regulation of lipopolysaccharide O antigen expression in Pseudomonas aeruginosa
Erica Kintz et al.
FUTURE MICROBIOLOGY (2008)
Lipopolysaccharide O-antigen chain length regulation in Pseudomonas aeruginosa serogroup O11 strain PA103
Erica Kintz et al.
JOURNAL OF BACTERIOLOGY (2008)
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals
O. Gutierrez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Immune evasion of the human pathogen Pseudomonas aeruginosa:: Elongation factor Tuf is a factor H and plasminogen binding protein
Ania Kunert et al.
JOURNAL OF IMMUNOLOGY (2007)
Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunity
Gerald B. Pier
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis
Pholawat Tingpej et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Structures of the core oligosaccharide and O-units in the R- and SR-type lipopolysaccharides of reference strains of Pseudomonas aeruginosa O-serogroups
OV Bystrova et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa
M Moller-Kristensen et al.
JOURNAL OF IMMUNOLOGY (2006)
Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia
CI Kang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Pseudomonas keratitis:: Protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases
A Caballero et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
The galU gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung
GP Priebe et al.
INFECTION AND IMMUNITY (2004)
Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development
M Matsukawa et al.
JOURNAL OF BACTERIOLOGY (2004)
The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia
SL Mueller-Ortiz et al.
INFECTION AND IMMUNITY (2004)
Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia
E Chamot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Elucidation of the structure of the lipopolysaccharide core and the linkage between the core and the O-antigen in Pseudomonas aeruginosa immunotype 5 using strong alkaline degradation of the lipopolysaccharide
OV Bystrova et al.
BIOCHEMISTRY-MOSCOW (2003)
Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1
AS Nouwens et al.
MICROBIOLOGY-SGM (2003)
Human Toll-like receptor 4 recognizes host-specific LPS modifications
AM Hajjar et al.
NATURE IMMUNOLOGY (2002)
Biofilms: Survival mechanisms of clinically relevant microorganisms
RM Donlan et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Extracellular DNA required for bacterial biofilm formation
CB Whitchurch et al.
SCIENCE (2002)
Biofilm formation: A clinically relevant microbiological process
RM Donlan
CLINICAL INFECTIOUS DISEASES (2001)
Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis
GB Pier et al.
INFECTION AND IMMUNITY (2001)
Share Paper
